New hope for sudden heart failure crises?
NCT ID NCT07262723
Summary
This study is testing a drug called levosimendan for people hospitalized with a sudden, severe worsening of heart failure. It will compare the drug added to standard care against standard care alone in 332 patients across Bangladesh. The main goal is to see if the drug safely helps patients feel better and improves their heart function in the short and long term.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE (ADHF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Apollo Imperial Hospital & Max Hospital
Chittagong, 4202, Bangladesh
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Chattogram Maa-O-Shishu Hospital Medical College Hospital
Chittagong, 4100, Bangladesh
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Chittagong Medical College Hospital, Chattogram
Chittagong, 4000, Bangladesh
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Cox's Bazar Medical College
Cox’s Bāzār, 4700, Bangladesh
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
National Institute of Cardiovascular Diseases
Dhaka, 1207, Bangladesh
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
United Hospital Limited
Dhaka, 1212, Bangladesh
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.